Has Eric Slotkin, DO received payments from drug or device companies?

Yes. Drug and device makers reported $210,338 in general payments to Eric Slotkin, DO across 191 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Eric Slotkin, DO did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Eric Slotkin, DO come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Eric Slotkin, DO

Orthopaedic Surgery · West Reading, PANPI 1063677185

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $165,625 of the $210,338 with a category attached, or 78.7%. 14 manufacturers reported payments, led by Omnilife Science, Inc at 46.9% of the total. Among orthopaedic surgery clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$210,338in general payments, 2019–2025

Across 191 payments — averaging $1101.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Omnilife Science, Inc$99K
UOC USA Inc$55K
Ortho Development Corporation$25K
Corin USA$16K
Naviswiss, Inc.$7K
Medical Device Business Services, Inc.$7K
plus $2K from 8 others

$44,428in ownership & investment interests, 2019–2025

Across 3 payments — averaging $14,809 each. An ownership or investment interest held by the physician or an immediate family member.

Omnilife Science, Inc$37K
Naviswiss, Inc.$7K

What the payments were for

Consulting fees$165,62579%
Speaking & faculty fees$8,0004%
Travel & lodging$30,61815%
Food & beverage$5,9423%
Gifts$1140%
Other$390%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Omnilife Science, Inc	109	$98,645
UOC USA Inc	23	$54,860
Ortho Development Corporation	14	$25,246
Corin USA	13	$15,641
Naviswiss, Inc.	14	$7,314
Medical Device Business Services, Inc.	5	$6,975
Novus Surgical Consultants	3	$720
Arthrex	2	$451
Engage Uni, LLC	2	$168
Henry Schein, Inc.	2	$139
Peter Brasseler Holdings, LLC	1	$115
Baxter Healthcare	1	$39
Johnson & Johnson	1	$16
Heraeus Medical, LLC.	1	$9

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Various Products$55,200
U2 PSI$20,000
Corin Technology$14,540
CONFORMITY, U2$13,300
Balance Knee Revision System$10,621
BKS Uni$10,500
U2, Conformity, U-Motion II and USTAR II$9,014
PSA, USTAR II, PSI$7,700
OMNIBotics 3.0$7,245
ATTUNE$6,975
Naviswiss Knee Navigation$5,400
OMNIBotics v 2.7$4,200
UTS, Conformity, U-MII, U2 Revision Stem, PSA, USTAR, U2 Knee$3,605
Unity$3,600
Ovation Hip Stem$1,735
Escalade Acetabular System$1,735
Balanced Knee System$1,627
Naviswiss Hip/Knee Navigation$929
Entrada Hip Stem$771
Naviswiss Hip navigation$600

How this compares

$210,338 in reported general payments places this provider in the 95th percentile of 1,048 orthopaedic surgery providers in Pennsylvania.

See all orthopaedic surgery providers in Pennsylvania →

Medicare billing

Part B allowed, 2024

$565,049

Medicare patients

862

Services billed

6,025

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	17	$5,124
Oxycodone Hcl	401	$4,106
Meloxicam	536	$1,355
Cyclobenzaprine Hcl	155	$1,111
Diclofenac Sodium	27	$969
Gabapentin	83	$874
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	63	$853
Pantoprazole Sodium	121	$757
Tramadol Hcl	155	$710
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	47	$528
Celecoxib	30	$508
Amoxicillin	84	$182
Tizanidine Hcl	11	$123
Silver Sulfadiazine	13	$89
Furosemide	14	$84

Paid to pharmacies, not to this prescriber.